Senior Scientific Director
Janssen R&D
Spring House, Pennsylvania
Dr. Weirong Wang is the Senior Scientific Director of the Clinical Translational Modeling group in the Clinical Pharmacology and Pharmacometrics Department, Janssen Research & Development, LLC (Johnson & Johnson). Dr. Wang has over 20 years of experience in discovery and development of biotherapeutics. Currently her team is responsible for using mechanism-based PK/PD and QSP modeling to support Janssen clinical portfolio across multiple therapeutic areas, including novel modalities such as T cell redirecting bispecific agents, CAR-Ts, and gene therapy.
Dr. Wang received her B.S. from Fudan University in China and her Ph.D. from Rutgers, the State University of New Jersey. She joined Janssen in 2011 and has led multiple groups focusing on mechanism- and physiologically-based modeling for translational purposes. Prior to join Janssen, Weirong worked at Merck & Co. and a biotech company called CuraGen. She has authored or co-authored more than 50 peer-reviewed papers, reviews and book chapters.
Disclosure information not submitted.
Wednesday, October 19, 2022
8:30 AM – 9:00 AM ET